Syntaxis Company

Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.

Last Funding Type: Seed
Headquarters: Lund, Skane Lan, Sweden
Founded Date: 2017-01-01
Investor Type: For Profit
Total Funding: €200K
Technology: NeuroTech
Employee Number: 1-10
Estimated Revenue: Less than $1M
Investors Number: 2
Industry: Biotechnology, Health Care, Science and Engineering